Krupiński K, Breddin H, Bielawiec M
Klinika Hematologii Akademii Medycznej, Białymstoku.
Kardiol Pol. 1993 Aug;39(8):100-4.
Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil obtained from the Casela Riedel Pharma GmbH, Frankfurt/Main, Germany have been studied in the laser-induced rat thrombosis model. The investigations were carried out on male Wistar rats weighing 200-300 g. Thrombus formation was induced in small mesenteric arteries--25-35 microns diameter using argon laser. An interference contrast system based on a Leitz Orthoplan microscope for the evaluation of thrombus formation was used. The number of laser injuries needed to induce a defined thrombus proved to be a useful way to quantitate the results in this thrombosis model. All agents showed dose dependent antithrombotic effect in our laser model. Molsidomine and verapamil inhibited 30 min after single i.v. injection in minimal dose 1 mg/kg and in dose 5 mg/kg 2 hours after oral administration thrombus formation in small mesenteric arteries. Isosorbide dinitrate in higher doses: 10 mg/kg 30 min after i.v. injection and 20 mg/kg after oral feeding showed significant antithrombotic effect. Antithrombotic effect of administration of minimal effective doses of all agents lasted longer than 4 hours but less than 6 hours. All drugs in effective antithrombotic doses after intravenous injection showed also inhibitory effect on rat platelet adhesion to the siliconized glass and bovine subendothelial extracellular matrix.
已在激光诱导的大鼠血栓形成模型中研究了从德国美因河畔法兰克福的卡塞拉·里德尔制药有限公司获得的吗多明、硝酸异山梨酯和维拉帕米的抗血栓作用。研究在体重200 - 300克的雄性Wistar大鼠身上进行。使用氩激光在直径为25 - 35微米的小肠系膜小动脉中诱导血栓形成。使用基于Leitz Orthoplan显微镜的干涉对比系统来评估血栓形成。在这个血栓形成模型中,诱导形成确定血栓所需的激光损伤次数被证明是定量结果的一种有用方法。在我们的激光模型中,所有药物均显示出剂量依赖性抗血栓作用。吗多明和维拉帕米在单次静脉注射1毫克/千克的最小剂量后30分钟以及口服5毫克/千克剂量2小时后,可抑制小肠系膜小动脉中的血栓形成。硝酸异山梨酯在较高剂量下:静脉注射后30分钟10毫克/千克以及口服后20毫克/千克显示出显著的抗血栓作用。所有药物最小有效剂量给药后的抗血栓作用持续超过4小时但少于6小时。静脉注射有效抗血栓剂量的所有药物对大鼠血小板黏附于硅化玻璃和牛内皮下细胞外基质也有抑制作用。